Cite
HARVARD Citation
Vandewalle, B. et al. (2016). Pharmacoeconomics of ruxolitinib therapy in patients with myelofibrosis. Journal of medical economics. pp. 424-431. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Vandewalle, B. et al. (2016). Pharmacoeconomics of ruxolitinib therapy in patients with myelofibrosis. Journal of medical economics. pp. 424-431. [Online].